Custom made Controls are made to access in-housed IVD products. A common mistake is to use of CE marked controls in-house IVD protocols and or feasibility researches studies . Commonly commercial control are made with predetermined 'intended uses' and not entirely applicable to new developments
The structure and content of ISO 15189:2022 have been revised.
For IQC Standards 7.3.7.2 focus is on specifications based on the intended clinical application of the examination.
The IQC section has been expanded from three subclauses to seven (a-g) where ‘a’ is defined as:
a1) The intended clinical application of the examination should be considered, as the performance specifications for the same measurand can differ in different clinical settings.
When designing an appropriate QC strategy several risk factors need to be taken into consideration:
Manufactured based on the intended clinical application specifications of the examination to monitor.
They are designed to deliver an unbiased and independent assessment of performance with any instrument or method, enabling laboratories to gain accreditation and ensure optimum performance and accuracy in clinical laboratory.
Embed Third party controls in clinical testing to cover critical decision points to avoid testing accreditation noncompliance.
Remember, IQC is not just about compliance; it is about managing quality effectively. Implementing correct levels of IQC in a medical laboratory is essential to ensure accurate and reliable test results.
ISOChecks.co.uk